by Peter Ciszewski | Jul 6, 2020
Susan Samson, MD, PhD of Baylor College of Medicine talks about the recently approved Mycapssa (octreotide) capsules as long-term maintenance therapy for people with acromegaly. Mycapssa is the only oral form of octreotide, a somatostatin analog, approved by...
by Peter Ciszewski | Jul 5, 2020
Bruce Cree, MD at the University of California San Francisco discusses some of the early symptoms of neuromyelitis optica spectrum disorder (NMOSD) that neurologists, ophthalmologists, and gastroenterologists should be aware of to speed up the diagnosis of this...
by Peter Ciszewski | Jun 30, 2020
Bruce Cree, MD of the University of California San Francisco discusses current treatment options for neuromyelitis optica spectrum disorder (NMOSD). NMOSD is a rare central nervous disorder that primarily affects the spinal cord and optic nerves. Symptoms of...
by Peter Ciszewski | Jun 29, 2020
Courtney Dinardo, MD from MD Anderson Cancer Center discusses the results of the phase 3 VIALE-A study, examining the combination of venetoclax and azacitidine as treatment for acute myeloid leukemia (AML). The results of this study showed this combination was more...
by Peter Ciszewski | Jun 26, 2020
The U.S. Food and Drug Administration has approved Fintepla (fenfluramine) to treat seizures associated with Dravet syndrome in patients age 2 and older. Dravet syndrome is a rare neurological condition that usually appears during the first year of life as frequent...
